Filing Flows › Edwards Lifesciences (EW) › Free cash flow
Edwards Lifesciences (EW) free cash flow by quarter
Edwards Lifesciences' free cash flow was $507M in Q3 2026 (third quarter 2026), -13% from Q2 2026. Over the last 6 quarters it ranged from $224M (Q1 2025) to $585M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $507M | -13% | -2% |
| Q2 2026 | $585M | +65% | +143% |
| Q4 2025 | $354M | -32% | — |
| Q3 2025 | $516M | +114% | — |
| Q2 2025 | $241M | +7% | — |
| Q1 2025 | $224M | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' free cash flow?
Edwards Lifesciences' free cash flow was $507M in Q3 2026 (third quarter 2026), -13% from Q2 2026.
How has Edwards Lifesciences' free cash flow changed?
Over the last 6 quarters it ranged from $224M (Q1 2025) to $585M (Q2 2026).